2Creasman WT, Odicino F, Maisonneuve P, et al. Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treat-ment in gynecological cancer [ J ]. Int J Gynecol Obstet ,2006,95 ( Suppl 1 ) : S105-143.
3Kurman ILl, Kaminski PF, Norris HJ. The behavior of en- dometrial hyperplasia. A long-term study of" untreated" hy- perplasia in 170 patients [ J ]. Cancer, 1985,56 (2) : 403- 411.
4Leitao MM Jr, Han G, Lee LX,et al. Complex atypical hy- perplasia of the uterus:characteristics and prediction of underlying carcinoma risk [ J ], Am J Obstet Gynecol, 2010,205(4) :349. e1-6.
5Baker J, Obermair A, Gebski V, et al. Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early en- dometrial adenocarcinoma:a meta-analysis and systematic review of the literature [ J ]. Gynecol Oncol, 2012, 125 ( 1 ) :263-270.
6Park JY, Kim DY, Kim JH, et al. Long-term oncologic out- comes after fertility-sparing management using oral proges- tin for young women with endometrial cancer (KGOG 2002) [J]. Eur J Cancer,2013,49(4) :868-874.
7Reed SD, Newton KM, Garcia RL, et al. Complex hyper- plasia with and without atypia : clinical outcomes and im- plications of progestin therapy [ J ]. Obstet Gynecol,2010, 116(2) :365-373.
8Gunderson CC, Fader AM, Carson KA, et al. Oncologie and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adeno- carcinoma: A systematic review [ J ]. Gynecol Oneol, 2012,125(2) :477-482.
9Jadoul P,Donnez J. Conservative treatment may be benefi- cial for young women with atypical endometrial hyperplasia or endometrial adenoearcinoma [ J ]. Fertil Steril, 2003,80 (6) :1315-1324.
10\-i - Kurman RJ, Norris HJ, et al. Evaluation of criteria for distinguishing atypical endometrial hyper-plasia from well-differentiated carcinoma [ J ]. Cancer, 1982, 49 (12) :2547-2559.
5Pollegioni L, Wels G, Pilone MS, et al. Kinetic mechanisms of cholesterol oxidase from Streptomyces hygroscopicus and Brevibacte- rium sterolicum [ J] . European Journal of Biochemistry, 1999,264 (1) :140-151.
7Gunderson CC,Fader AM,Carson KA,et al.Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma:A systematic review[J].Gynecol Oncol,2012,125(2):477-482.
8Jikihara H,Terada N,Yammoto R,et al.Inhiitory eff ect of medroxyprogeterone acetate on angiogenes is induced by human endometrial cancer[J].Am J Obstet Gynecol,1992,167(1):207-211.
9Ota T,Yoshida M,Kimur T M,et al.Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger[J].Int J Gynecol Cancer,2005,15(4):657-662.
10Bourlev V,Iljasova N,Adamyan L,et al.Signs of reduced angiogenic activity after surgical removal of deeply infiltrating endometriosis[J].Fertil Steril,2010,94(1):52-57.
